UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) P-accRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 15.2 | 16.9 | -12.9 | 2.8 | 4.4 | |
+/-Cat | 10.9 | 1.6 | -4.6 | -8.7 | 0.6 | |
+/-B’mrk | 12.6 | -0.8 | -8.3 | -10.4 | -1.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 22/11/2024 | EUR 286.94 | |
Day Change | 1.18% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU0723564463 | |
Fund Size (Mil) 22/11/2024 | EUR 411.95 | |
Share Class Size (Mil) 22/11/2024 | EUR 165.77 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 18/11/2024 | 2.00% |
Investment Objective: UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) P-acc |
This actively managed sub-fund predominantly invests in equities, equity rights or other equity interests in companies domiciled or chiefly active in Europe. The UBS ESG consensus score is used to identify issuers/companies for the investment universe with strong environmental and social performance characteristics, or a strong sustainability profile. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Kevin Barker 31/07/2024 | ||
Marie Paske 31/07/2024 | ||
Click here to see others | ||
Inception Date 14/06/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) P-acc | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 4.39 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 3.95 |
Novo Nordisk AS Class B | Healthcare | 3.86 |
Ashtead Group PLC | Industrials | 3.54 |
HSBC Holdings PLC | Financial Services | 3.49 |
Increase Decrease New since last portfolio | ||
UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) P-acc |